Red-emissive azabenzanthrone derivatives for photodynamic therapy irradiated with ultralow light power density and two-photon imaging
Citations Over TimeTop 10% of 2018 papers
Abstract
Photodynamic therapy has proved to be an effective strategy for cancer therapy, and advanced photosensitizers for image-guided photodynamic therapy require biocompatibility, intense absorption, high ROS generation efficiency, phototoxicity, low irradiation power density and efficient emission. In this work, four red emissive azabenzanthrone derivatives have been designed and synthesized, which generally exhibit efficient aggregated state emission. Through structural optimization, 3-diphenylamino-11-azabenzanthrone was found to show satisfactory photo-induced ROS generation and high emission efficiency in the aggregated state. Under the irradiation of a white LED lamp with an ultralow power density of 1.67 mW cm-2, this compound demonstrates significant photo-induced cytotoxicity toward HeLa cells. Moreover, deep tissue penetration can be realized by two-photon imaging of mouse brain vessels with these azabenzanthrone derivatives at vertical depths of up to 280 μm, attributed to the large emission wavelength and efficient emission.
Related Papers
- → Activatable Type I Photosensitizer with Quenched Photosensitization Pre and Post Photodynamic Therapy(2023)120 cited
- → Isomeric effect on the properties of tetraplatinated porphyrins showing optimized phototoxicity for photodynamic therapy(2017)51 cited
- → Comparison between porphin, chlorin and bacteriochlorin derivatives for photodynamic therapy: Synthesis, photophysical properties, and biological activity(2018)49 cited
- → The characteristics of erythema induced by topical 5‐aminolaevulinic acid photodynamic therapy(2004)18 cited
- → Management for Phototoxicity after Photodynamic Therapy Using Talaporfin Sodium(2019)3 cited